Literature DB >> 9834925

Oxalogenesis in parenteral nutrition solution components.

G F Rockwell1, T Campfield, B C Nelson, P C Uden.   

Abstract

Oxalate has been implicated in the etiology of nephrocalcinosis in premature infants as well as in the formation of insoluble precipitates in total parenteral nutrition (TPN) intravenous tubing. Oxidation of ascorbate to oxalate, especially in the presence of catalysts such as copper and iron, has been implicated in formation of these precipitates. The purpose of this project was to measure oxalate formation in certain TPN components separately and in combination. Neonatal TPN solution components in combination were infused at 5 mL/h under simulated clinical conditions used in a neonatal intensive care unit. Aliquots were assayed at intervals for oxalate by capillary electrophoresis. Oxalate is present in one TPN mixture at concentrations up to 8 ppm. The addition of ascorbate to an aqueous solution of trace metals may promote oxalogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834925     DOI: 10.1016/s0899-9007(98)00104-x

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

1.  Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

Authors:  Vasilios I Giapros; Athanasios L Papaloukas; Anna S Challa; Panagiotis D Nikolopoulos; Constantine G Tsampoulas; Styliani K Andronikou
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

2.  Oxalic acid excretion after intravenous ascorbic acid administration.

Authors:  Line Robitaille; Orval A Mamer; Wilson H Miller; Mark Levine; Sarit Assouline; David Melnychuk; Caroline Rousseau; L John Hoffer
Journal:  Metabolism       Date:  2009-02       Impact factor: 8.694

3.  High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.

Authors:  David J Cranefield; David E Odd; Jane E Harding; Rita L Teele
Journal:  Pediatr Radiol       Date:  2003-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.